▲ Applicants who perform blood sampling on the 7th day after vaccination in clinical trials


China has completed the first clinical trial to develop the Corona19 vaccine, the Chinese media reported.

According to the Changjiang Daily of China, the Chinese Vaccine Clinical Research Team yesterday (2nd) awarded 108 letters to the 108 participants in the clinical trial, saying, "Thank you and thank you for the smooth vaccination."

Earlier, the Chinese authorities approved the first phase 1 clinical trial of the Corona 19 vaccine by the Military Research Institute on the 17th of last month.

The researchers sequentially vaccinated 108 residents of Wuhan, Hubei Province, where Corona 19 first spread, and quarantined the facility for 14 days.

Among them, 18 volunteers completed the containment period and returned to their daily lives, and it was reported that they were in good health.

The research team will examine and re-examine them for 6 months after the quarantine period, to confirm the formation of antibodies.

One of the volunteers, Chunkai, said, "I had a mild fever and headache on the first day after vaccination, but it disappeared soon."

Hong Kong Media South China Morning Post said the results of the first clinical trials will be released later this month.

China plans to conduct large-scale 2nd and 3rd clinical trials in the future, and plans to conduct follow-up studies abroad even in severe Corona19 situations are being considered.

(Photo = Hubei Provincial Hygiene and Health Committee, Yonhap News)